J Menopausal Med.  2015 Dec;21(3):160-164. 10.6118/jmm.2015.21.3.160.

Mucinous Borderline Ovarian Tumor in Very Old Aged Postmenopausal Woman

• Lee SH
• Kim TH
• Lee HH
• Lee A
• Kim YS
• Jeon DS
• Kwak JJ
• Yang YS

• KMID: 2200970
• DOI: http://doi.org/10.6118/jmm.2015.21.3.160

Abstract

Mucinous borderline ovarian tumors (BOTs) occur most often in women between the ages of 20 and 30. Early-stage detection of the condition has a more favorable prognosis. In this case report, the authors present an elderly 93-year old woman who visited our hospital due to severe abdominal pain after being diagnosed with a pelvic mass 2 years ago and not undergoing any treatment since the diagnosis was made. She underwent emergency left salpingo-oophorectomy and was diagnosed with mucinous BOT according to biopsy results.

Keyword

Aged; Cystadenoma mucinous; Female; Ovarian neoplasms

MeSH Terms

Abdominal Pain
Aged
Biopsy
Diagnosis
Emergencies
Female
Humans
Mucins*
Ovarian Neoplasms
Prognosis
Mucins

Figure

• 

  Fig. 1 About 15 cm sized huge cystic mass in lower abdomen with ascites (computed tomography).

• 

  Fig. 2 About 15 × 9 cm sized large multiloculated cystic mass with ascites, probable left ovary origin epithelial tumor (magnetic resonance image).

• 

  Fig. 3 Photography of left ovarian mass, sized 16.5 × 12.0 × 9.5 cm and weighed 980 g.

• 

  Fig. 4 On cut section The lesion is multilocular cystic mass (16.5 × 12.0 × 9.5 cm) in ovary. The outer surface is whitish gray, smooth and intact. The inner surface is smooth and filled with gelatinous contents.

Reference

1. Tinelli R, Tinelli A, Tinelli FG, Cicinelli E, Malvasi A. Conservative surgery for borderline ovarian tumors: a review. Gynecol Oncol. 2006; 100:185–191.

2. Kottmeier HL, Kolstad P, McGarrity KA. Annual report on the results of treatment in gynaecologic cancer vol 17, statements of results obtained in 1969-1972, inclusive. Stockholm, SE: Editorial office, Radiumhemmet: FIGO;1973.

3. Serov SF, Scully RE, Sobin LH. International histological classification of tumors, no 9 histoloigcal typing of ovarian tumours. Geneva, CH: World Health Organization;1973.

4. Morice P, Uzan C, Fauvet R, Gouy S, Duvillard P, Darai E. Borderline ovarian tumour: pathological diagnostic dilemma and risk factors for invasive or lethal recurrence. Lancet Oncol. 2012; 13:e103–e115.

5. Exacoustos C, Romanini ME, Rinaldo D, Amoroso C, Szabolcs B, Zupi E, et al. Preoperative sonographic features of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005; 25:50–59.

6. Sulkin TV, O'Neill H, Amin AI, Moran B. CT in pseudomyxoma peritonei: a review of 17 cases. Clin Radiol. 2002; 57:608–613.

7. Stewart JHt, Shen P, Levine EA. Intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: current status and future directions. Ann Surg Oncol. 2005; 12:765–777.

8. Kim CR, Ku CH, Jeon IS, Son DW, Lee JS. The clinicopathologic features and significance of preoperative CA 125 in patients who had an operation for ovarian tumors. J Korean Soc Menopause. 2013; 19:26–35.

9. Park JW, Bae JW. Postmenopausal Meigs' Syndrome in Elevated CA-125: A Case Report. J Menopausal Med. 2015; 21:56–59.

10. Kolwijck E, Thomas CM, Bulten J, Massuger LF. Preoperative CA-125 levels in 123 patients with borderline ovarian tumors: a retrospective analysis and review of the literature. Int J Gynecol Cancer. 2009; 19:1335–1338.

11. Carmignani CP, Hampton R, Sugarbaker CE, Chang D, Sugarbaker PH. Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix. J Surg Oncol. 2004; 87:162–166.

12. Liu JH, Zanotti KM. Management of the adnexal mass. Obstet Gynecol. 2011; 117:1413–1428.

13. Sherman ME, Berman J, Birrer MJ, Cho KR, Ellenson LH, Gorstein F, et al. Current challenges and opportunities for research on borderline ovarian tumors. Hum Pathol. 2004; 35:961–970.

14. Park JM, Kim MK. Hereditary risk evaluation for borderline ovarian tumors based on immunohistochemistry. J Menopausal Med. 2014; 20:14–20.

15. Kim TH, Lee HH, Hong JA, Park J, Jeon DS, Lee A, et al. Sclerosing stromal tumor in an elderly postmenopausal woman. J Menopausal Med. 2014; 20:80–83.

16. Park J, Kim TH, Lee HH, Lee W, Chung SH. Ovarian rete cyst in a post-menopausal woman: a case report. J Korean Soc Menopause. 2012; 18:67–69.